ConductScience.org, home

Paper39752109

Canine mammary tumors as a promising adjunct preclinical model for human breast cancer research: similarities, opportunities, and challenges.

Bhutta ZA and 1 other. Arch Pharm Res, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Canine mammary tumors as a promising adjunct preclinical model for human breast cancer research: similarities, opportunities, and challenges. Papers, record 39752109. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39752109

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Canine mammary tumors as a promising adjunct preclinical model for human breast cancer research: similarities, opportunities, and challenges.
PubMed
Journal
Arch Pharm Res
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.56, provisional
iCite
Revised in PubMed
2025-05-20
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bhutta ZAZeeshan Ahmad
2Choi KCKyung-Chul

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Disease Models, AnimalMajor topic
Mammary Neoplasms, AnimalMajor topic
Animals
Dogs
Humans
Female

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2022R1A4A1025557National Research Foundation (NRF) of KoreaPubMed
MOENational Research Foundation (NRF) of KoreaPubMed
2021RIS-001National Research Foundation (NRF) of KoreaPubMed

Source PubMed

Download CSV of grants

References153

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115141381Expression of luminal and basal cytokeratins in human breast carcinoma.J Pathol2004https://conductscience.org/library/papers/15141381PubMed
236978614National Dog Survey: Describing UK Dog and Ownership Demographics.Animals (Basel)2023https://conductscience.org/library/papers/36978614PubMed
329961579Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment.Cell2018https://conductscience.org/library/papers/29961579PubMed
430514914Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing.Nat Commun2018https://conductscience.org/library/papers/30514914PubMed
537283510GH and IGF1 in cancer therapy resistance.Endocr Relat Cancer2023https://conductscience.org/library/papers/37283510PubMed
611323501Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53.Ann Surg2001https://conductscience.org/library/papers/11323501PubMed
729394917Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.BMC Cancer2018https://conductscience.org/library/papers/29394917PubMed
822847008Role of p63 in Development, Tumorigenesis and Cancer Progression.Cancer Microenviron2012https://conductscience.org/library/papers/22847008PubMed
928799073Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1.Curr Oncol Rep2017https://conductscience.org/library/papers/28799073PubMed
1039533509Phytochemicals as Novel Therapeutics for Triple-Negative Breast Cancer: A Comprehensive Review of Current Knowledge.Phytother Res2025https://conductscience.org/library/papers/39533509PubMed
1139345747Effect of punicalagin on the autophagic cell death in triple-negative breast cancer cells.Toxicol Res2024https://conductscience.org/library/papers/39345747PubMed
1224138885Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.Immunity2013https://conductscience.org/library/papers/24138885PubMed
1331730395The Acidic Tumor Microenvironment as a Driver of Cancer.Annu Rev Physiol2020https://conductscience.org/library/papers/31730395PubMed
1436768202Characterization of IGF2R Molecular Expression in Canine Osteosarcoma as Part of a Novel Comparative Oncology Approach.Int J Mol Sci2023https://conductscience.org/library/papers/36768202PubMed
1530057419CD4+ T cell help in cancer immunology and immunotherapy.Nat Rev Immunol2018https://conductscience.org/library/papers/30057419PubMed
1636983412Vascular Endothelial Growth Factor Ligands and Receptors in Breast Cancer.J Clin Med2023https://conductscience.org/library/papers/36983412PubMed
1733208018p53, ER, and Ki67 Expression in Canine Mammary Carcinomas and Correlation With Pathological Variables and Prognosis.Vet Pathol2021https://conductscience.org/library/papers/33208018PubMed
1822095586Cross-talk between endothelial and breast cancer cells regulates reciprocal expression of angiogenic factors in vitro.J Cell Biochem2012https://conductscience.org/library/papers/22095586PubMed
1919945040The ACR BI-RADS experience: learning from history.J Am Coll Radiol2009https://conductscience.org/library/papers/19945040PubMed
2032961915A Statistical Analysis of Risk Factors and Biological Behavior in Canine Mammary Tumors: A Multicenter Study.Animals (Basel)2020https://conductscience.org/library/papers/32961915PubMed

See all 153 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42798018p53 in Canine Mammary Tumors: From Molecular Pathogenesis to Biomarker Applications and Comparative Oncology.Vet Sci2026https://conductscience.org/library/papers/42798018PubMed
42620570PI3K over-expression drives canine mammary tumor progression.Front Vet Sci2026https://conductscience.org/library/papers/42620570PubMed
42510834Development of Autologous Dendritic Cell Vaccine Therapeutics for Canine Mammary Cancer.Genes (Basel)2026https://conductscience.org/library/papers/42510834PubMed
42509465FGFR4-associated APOBEC3 mutagenesis characterizes HER2-enriched subtype of human breast cancer.Br J Cancer2026https://conductscience.org/library/papers/42509465PubMed
42454670Enhancing EGFR Inhibition: Monensin and Erlotinib Synergize to Eliminate Cancer Stem Cells in Canine Mammary Tumours.Vet Comp Oncol2026https://conductscience.org/library/papers/42454670PubMed
41012800Comparative Genetics of Canine and Human Cancers.Vet Sci2025https://conductscience.org/library/papers/41012800PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39752109

GET https://conductscience.org/api/papers/v1/39752109/references?page=2